Connect Biopharma Holdings Limited Ordinary Shares

CNTBNASDAQ • USD
0.88 USD
↘ 0.02 (2.62%)🟢LIVE (AS OF 11:42 AM EDT)
🟢Market: OPEN

Shares of Connect Biopharma Holdings Limited Ordinary Shares (CNTB) are trading at $0.88. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, CNTB trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Oct 12, 2026.

Open?$0.90
High?$0.94
Low?$0.88
Prev. Close?$0.91
Volume?559.9K
Avg. Volume?7.7M
VWAP?$0.90
Rel. Volume?0.07x
Bid / Ask
Bid?$0.77 × 100
Ask?$1.03 × 100
Spread?$0.26
Midpoint?$0.90
Valuation & Ratios
Market Cap?57.3M
Shares Out?63.0M
Float?20.0M
Float %?31.8%
P/E Ratio?N/A
P/B Ratio?2.13
EPS?-$1.10
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
Employees
64
Market Cap
57.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2025-09-03
Address
3580 CARMEL MOUNTAIN ROAD, SUITE 200
SAN DIEGO, CA 92130
Phone: 858-727-1040
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
50
Short Sent.?
34
Piotroski F-Score?1/9Weak
Altman Z-Score?-16.68Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?17.46%High
Short Interest?3.5M
Days to Cover?1.0
Free Float20.0M
Avg Daily Volume16.0M
Settlement Date2026-09-30
Financial Health
Current Ratio?2.37Strong
Quick Ratio?2.37Strong
Cash Ratio?1.66Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
71
2.13CHEAP▾
P/S?
Peers
100
S&P
3
19.41HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.4CHEAP▾
EV/Sales?
Peers
100
S&P
10
10.26HIGH▾
Returns & Efficiency
ROE?
S&P
3
-257.9%WEAK▾
ROA?
S&P
3
-159.4%WEAK▾
Cash Flow & Enterprise
FCF?$-60633000
Enterprise Value?$30.3M
Fundamentals ratios updated end of day